You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Moderate to severe plaque psoriasis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis Trial (Placebo, Bimekizumab)

Not yet recruiting
  • Chronic Plaque Psoriasis
  • Moderate to Severe Chronic Plaque Psoriasis
  • (no location specified)
Aug 21, 2023

Tolerability in Pediatric Patients With Psoriasis

Not yet recruiting
  • Moderate-to-severe Plaque Psoriasis
  • Secukinumab
  • (no location specified)
Nov 16, 2023

Plaque Psoriasis Trial (JNJ-77242113, JNJ-77242113 Matching Placebo, Deucravacitinib)

Not yet recruiting
  • Plaque Psoriasis
  • (no location specified)
Nov 16, 2023

Deucravacitinib in Moderate-to-Severe Plaque Psoriasis in

Recruiting
  • Plaque Psoriasis
  • Selters, Rhineland-Palatinate, Germany
    Dermatologische Spezial- und Schwerpunktpraxis Selters
Oct 23, 2023

Plaque Psoriasis Trial (TAK-279, Placebo, Apremilast)

Not yet recruiting
  • Plaque Psoriasis
  • (no location specified)
Oct 12, 2023

Moderate-to-severe Plaque Psoriasis Patients Response to

Completed
  • Moderate-to-severe Plaque Psoriasis
    • Jakarta, Indonesia
      Mangga Besar Clinic
    Mar 15, 2023

    Plaque Psoriasis Trial (apremilast, Placebo)

    Not yet recruiting
    • Plaque Psoriasis
    • (no location specified)
    Nov 3, 2023

    Plaque Psoriasis Trial (TAK-279, Placebo, Apremilast)

    Not yet recruiting
    • Plaque Psoriasis
    • (no location specified)
    Oct 25, 2023

    Plaque Psoriasis Trial in Karachi (Secukinumab Injection)

    Completed
    • Plaque Psoriasis
    • Secukinumab Injection
    • Karachi, Sindh, Pakistan
      Jinnah Post graduate Medical centre
    Jun 4, 2023

    Psoriasis Trial (IBI112, IBI112/)

    Not yet recruiting
    • Psoriasis
    • (no location specified)
    Sep 19, 2023

    Validate Cumulative Life Course Impairment Instrument in Adult

    Not yet recruiting
    • Psoriasis
      • (no location specified)
      Jul 17, 2023

      Psoriasis Trial in Shanghai (HS-10374 tablets 1mg, HS-10374 tablets 5mg, HS-10374-matched tablets)

      Not yet recruiting
      • Psoriasis
      • HS-10374 tablets 1mg
      • +2 more
      • Shanghai, Shanghai, China
        Huashan Hospital of Fudan University
      Oct 8, 2023

      Patients Treated With Secukinumab for Moderate to Severe Plaque

      Completed
      • Plaque Psoriasis
      • Bangkok, Thailand
        Novartis Investigative Site
      Dec 6, 2022

      Plaque Psoriasis Trial in Pembroke Pines (TLL018 tablets)

      Recruiting
      • Plaque Psoriasis
      • TLL018 tablets
      • Pembroke Pines, Florida
        AQUA - Riverchase
      Mar 6, 2023

      Switching FromBiologic Treatment to Tildrakizumab Using

      Not yet recruiting
      • Plaque Psoriasis
      • (no location specified)
      Sep 1, 2023

      Moderate-to-Severe Plaque Psoriasis Trial in Shenyang (Jaktinib, Placebo)

      Recruiting
      • Moderate-to-Severe Plaque Psoriasis
      • Shenyang, Liaoning, China
        The First Affiliated Hospital of China Medical University
      Nov 28, 2022

      Psoriasis Trial in Lahore (Apremilast 30mg)

      Completed
      • Psoriasis
      • Apremilast 30mg
      • Lahore, Punjab, Pakistan
        Ghurki Hospital
      Sep 5, 2023

      Effects, Drug Side Trial in Shanghai (Placebo, SYHX1901)

      Recruiting
      • Effects, Drug Side
      • Shanghai, Shanghai, China
        Huashan Hospital Affiliated to Fudan University
      May 4, 2023

      Psoriasis Trial (SAR441566, Placebo)

      Not yet recruiting
      • Psoriasis
      • (no location specified)
      Oct 4, 2023

      Apremilast in Chinese Moderate to Severe Plaque Psoriasis,Multi

      Not yet recruiting
      • Psoriasis
      • Beijing, China
      • +1 more
      May 9, 2023

      Psoriasis Trial in Shanghai (IBI112, /IBI112)

      Not yet recruiting
      • Psoriasis
      • Shanghai, Shanghai, China
        Shanghai Skin Disease Hospital
      Dec 1, 2022

      Plaque Psoriasis Trial in United States (JNJ-77242113, Placebo)

      Recruiting
      • Plaque Psoriasis
      • Rolling Meadows, Illinois
      • +8 more
      Oct 18, 2023

      Moderate to Severe Chronic Plaque Psoriasis Trial (CT-P17, EU-approved Humira)

      Not yet recruiting
      • Moderate to Severe Chronic Plaque Psoriasis
      • CT-P17
      • EU-approved Humira
      • (no location specified)
      Aug 8, 2022

      Psoriasis Trial in Shanghai (LZM012, Secukinumab)

      Recruiting
      • Psoriasis
      • LZM012
      • Secukinumab
      • Shanghai, Shanghai, China
        Huashan Hospital
      Oct 29, 2023

      Healthcare Resource Utilization Among Adult Moderate-To-Severe

      Not yet recruiting
      • Psoriasis
        • Nanjing, Jiangsu, China
          Local Institution
        Sep 16, 2022